On June 27, the U.S. Food and Drug Administration (FDA) approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Read more.
Most Recent Content
For Nurse Practitioners
Menopause and Sleep Problems
Data shows that sleep disturbances increase in prevalence during the menopausal transition, with the most common complaint being nighttime awakenings.
Take our quick three-question survey...
